US Penicillin G Sodium Prices Moves 13.3% Higher in March 2026

US Penicillin G Sodium Prices Moves 13.3% Higher in March 2026

Jane Austen 30-Apr-2026

Penicillin G sodium prices in the United States moved sharply higher in March as tight import availability supported firmer spot offers. Early-month shipments from China and India were limited, while mid-month regulatory scrutiny and contamination incidents reduced exportable volumes. Hospitals and injectable manufacturers accelerated call-offs, with distributors reporting higher releases; livestock producers front-loaded purchases ahead of spring vaccination windows. Late-month activity left Houston free-trade-zone stocks near minimum cover and pressured buyers to accept firmer quotes, creating a bullish backdrop for CFR Houston spot supply into April. Demand across markets was uneven but supportive of higher pricing: healthcare strengthened as hospitals and injectables increased spot tenders and substituted Penicillin G for out-of-stock cefuroxime injectables; retail pharmacy demand remained weak as oral derivatives dominate. Livestock and veterinary demand was moderate due to spring metaphylaxis programs. Upstream costs rose, lifting variable fermentation expenses. ChemAnalyst projects continued firmness into spring.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.